Lerna Uzasci1,2, Sungyoung Auh3, Robert J Cotter2, Avindra Nath1. 1. Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. 2. The Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. 3. Clinical Neurosciences Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Abstract
PURPOSE: To map the phosphoproteome and identify changes in the phosphorylation patterns in the HIV-infected and uninfected brain. EXPERIMENTAL DESIGN: Parietal cortex from individuals with and without HIV infection were lysed and trypsinized. The peptides were labeled with iTRAQ reagents, combined, phospho-enriched by titanium dioxide chromatography, and analyzed by LC-MS/MS with high resolution. RESULTS: Our phosphoproteomic workflow resulted in the identification of 112 phosphorylated proteins and 17 novel phosphorylation sites in all the samples that were analyzed. The phosphopeptide sequences were searched for kinase substrate motifs, which revealed potential kinases involved in important signaling pathways. The site-specific phosphopeptide quantification showed that peptides from neurofilament medium polypeptide, myelin basic protein, and 2'-3'-cyclic nucleotide-3' phosphodiesterase have relatively higher phosphorylation levels during HIV infection. CONCLUSIONS AND CLINICAL RELEVANCE: This study has enriched the global phosphoproteome knowledge of the human brain by detecting novel phosphorylation sites on neuronal proteins and identifying differentially phosphorylated brain proteins during HIV infection. Kinases that lead to unusual phosphorylations could be therapeutic targets for the treatment of HIV-associated neurocognitive disorders.
PURPOSE: To map the phosphoproteome and identify changes in the phosphorylation patterns in the HIV-infected and uninfected brain. EXPERIMENTAL DESIGN: Parietal cortex from individuals with and without HIV infection were lysed and trypsinized. The peptides were labeled with iTRAQ reagents, combined, phospho-enriched by titanium dioxide chromatography, and analyzed by LC-MS/MS with high resolution. RESULTS: Our phosphoproteomic workflow resulted in the identification of 112 phosphorylated proteins and 17 novel phosphorylation sites in all the samples that were analyzed. The phosphopeptide sequences were searched for kinase substrate motifs, which revealed potential kinases involved in important signaling pathways. The site-specific phosphopeptide quantification showed that peptides from neurofilament medium polypeptide, myelin basic protein, and 2'-3'-cyclic nucleotide-3' phosphodiesterase have relatively higher phosphorylation levels during HIV infection. CONCLUSIONS AND CLINICAL RELEVANCE: This study has enriched the global phosphoproteome knowledge of the human brain by detecting novel phosphorylation sites on neuronal proteins and identifying differentially phosphorylated brain proteins during HIV infection. Kinases that lead to unusual phosphorylations could be therapeutic targets for the treatment of HIV-associated neurocognitive disorders.
Authors: Adolf Pfefferbaum; David A Rogosa; Margaret J Rosenbloom; Weiwei Chu; Stephanie A Sassoon; Carol A Kemper; Stanley Deresinski; Torsten Rohlfing; Natalie M Zahr; Edith V Sullivan Journal: Neurobiol Aging Date: 2014-01-13 Impact factor: 4.673
Authors: Huanyu Dou; Brent Ellison; Jennifer Bradley; Alexander Kasiyanov; Larisa Y Poluektova; Huangui Xiong; Sanjay Maggirwar; Stephen Dewhurst; Harris A Gelbard; Howard E Gendelman Journal: J Neurosci Date: 2005-09-14 Impact factor: 6.167
Authors: Christina Patrick; Leslie Crews; Paula Desplats; Wilmar Dumaop; Edward Rockenstein; Cristian L Achim; Ian P Everall; Eliezer Masliah Journal: Am J Pathol Date: 2011-04 Impact factor: 4.307
Authors: Wojciech Rozek; Mary Ricardo-Dukelow; Sondra Holloway; Howard E Gendelman; Valerie Wojna; Loyda M Melendez; Pawel Ciborowski Journal: J Proteome Res Date: 2007-10-12 Impact factor: 4.466
Authors: Mehrdad Alirezaei; Debbie D Watry; Claudia F Flynn; William B Kiosses; Eliezer Masliah; Bryan R G Williams; Marcus Kaul; Stuart A Lipton; Howard S Fox Journal: J Neurosci Date: 2007-10-10 Impact factor: 6.167